Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP547470.RA6Fmym2zWk9PJT61EROxLWwCt46e1j37OL4_UAaVsy_8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP547470.RA6Fmym2zWk9PJT61EROxLWwCt46e1j37OL4_UAaVsy_8130_assertion type Assertion NP547470.RA6Fmym2zWk9PJT61EROxLWwCt46e1j37OL4_UAaVsy_8130_head.
- NP547470.RA6Fmym2zWk9PJT61EROxLWwCt46e1j37OL4_UAaVsy_8130_assertion description "[In this study, we further characterized the FL3B lymphomas that are currently part of the spectrum of FL in the WHO classification, taking into account other cytogenetical aberrations, immunohistochemistry for P53, bcl2, bcl6, and CD10, rearrangement of the proto-oncogene myc, and mutation of the tumor suppressor gene TP53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547470.RA6Fmym2zWk9PJT61EROxLWwCt46e1j37OL4_UAaVsy_8130_provenance.
- NP547470.RA6Fmym2zWk9PJT61EROxLWwCt46e1j37OL4_UAaVsy_8130_assertion evidence source_evidence_literature NP547470.RA6Fmym2zWk9PJT61EROxLWwCt46e1j37OL4_UAaVsy_8130_provenance.
- NP547470.RA6Fmym2zWk9PJT61EROxLWwCt46e1j37OL4_UAaVsy_8130_assertion SIO_000772 16647949 NP547470.RA6Fmym2zWk9PJT61EROxLWwCt46e1j37OL4_UAaVsy_8130_provenance.
- NP547470.RA6Fmym2zWk9PJT61EROxLWwCt46e1j37OL4_UAaVsy_8130_assertion wasDerivedFrom befree-2016 NP547470.RA6Fmym2zWk9PJT61EROxLWwCt46e1j37OL4_UAaVsy_8130_provenance.
- NP547470.RA6Fmym2zWk9PJT61EROxLWwCt46e1j37OL4_UAaVsy_8130_assertion wasGeneratedBy ECO_0000203 NP547470.RA6Fmym2zWk9PJT61EROxLWwCt46e1j37OL4_UAaVsy_8130_provenance.